Eli Lilly's Animal-Health Unit Raises $1.5 Billion in IPO
*By Michael Teich*
Wall Street seems to have an appetite for Elanco.
Stock in the animal healthcare start-up that sells antibiotics for pets and livestock surged 50 percent in its market debut Thursday. Shares closed at $36 after pricing at $24 in the IPO ー a price that was already above the expected range of $20 to $23 a share.
Although the company may be relatively unknown to traders, Elanco is a household name among players in the animal healthcare industry, CEO Jeff Simmons told Cheddar.
“We may be new here on Wall Street, but we’re not new in the market for veterinarians and for farmers. We’ve been out there for more than six decades," he said.
Elanco, which spun out of pharmaceutical giant Eli Lilly in July, generates two-thirds of its $2.9 billion in revenue from drugs given to livestock ー cattle and chicken, for example.
The use of antibiotics in livestock has been a polarizing issue among consumers.
In its S-1 IPO filing, the company mentioned one risk to its outlook was the preference for dairy products produced without antibiotics.
Simmons, however, said the trend is actually an opportunity for the company and argued the medication creates safer food products.
“It all starts with a healthy animal. A healthy animal creates safe high quality meat milk and eggs,” he said. “We gotta come on and make sure that animal stays healthy.”
Food animal medicines and vaccines raked in $21.2 billion in revenue in 2017, according to research and consulting firm Vetnosis, and the industry is not expected to slow down any time soon.
According to data firm [Research and Markets](https://www.prnewswire.com/news-releases/global-animal-healthcare-market-2017-2025---a-53-billion-market-potential-300577550.html), the global market for animal healthcare is forecast to be worth $53.42 billion by 2025.
For full interview [click here](https://cheddar.com/videos/animal-medicine-company-elanco-surges-in-market-debut).
After the 2021 boom, IPO activity slowed down significantly, in part due to monetary policy – but things are getting moving again with tech-friendly companies like Iboutta and Rubrik making a public debut.
With an increasing demand for mental health services, one person wanted to change the therapy game. In 2017, CEO Alex Katz founded Two Chairs, a company that uses technology to match patients with the right therapist.
Not only is April Financial Literacy Month, it’s also the kickoff of the spring homebuying season. So now is the time to make sure you have a financial plan in place – and why it might not be wise for that to include buying your first home.
While the U.S. may slowly be on the path to lowering inflation (and therefore interest rates), Europe has thoroughly trounced America, putting it on the path to lower rates by this summer.
April's release of the monthly Housing Starts and Building Permits reports by the Census Bureau provides crucial insights into the construction activity in the housing market. These reports are an economic indicator, shedding light on the current state of the housing market and its broader economic impact.
Caitlin Clark is heading to the Indiana Fever, the number one draft pick and the highest-scoring college basketball player of all time. And while she may not be getting millions from the WNBA, there's a few ways she'll net compensation for her generational talents.
Author of 'Clean Meat,' Paul Shapiro joins Cheddar to discuss how the cellular agricultural revolution helps lower rates of foodborne illness and greatly improves environmental sustainability. Plus, how his company The Better Meat Co. is bringing healthier food options to the table.
Recent headlines might make it sound like World War III is imminent, but when it comes to your finances, it's not the time to panic. The market is coming off its longest winning streak since 2011.
You may have noticed fewer new venture capital-backed startups (like Airbnb or Uber) lately. The market slowed to a crawl after 2021, but things are expected to take off again in 2025.
Corporate earnings season is underway, that time when companies share their billions in sales or double-digit profits. But the data shows even companies are struggling with high inflation and interest rates.
